AAAAAA
Results:
1-15
|
Results: 15
Authors:
Schlette, E
Bueso-Ramos, C
Giles, F
Glassman, A
Hayes, K
Medeiros, LJ
Citation: E. Schlette et al., Mature B-cell leukemias with more than 55% prolymphocytes - A heterogenousgroup that includes an unusual variant of mantle cell lymphoma, AM J CLIN P, 115(4), 2001, pp. 571-581
Authors:
Estey, E
Koller, C
Cortes, J
Reed, P
Freireich, E
Giles, F
Kantarjian, H
Citation: E. Estey et al., Treatment of newly-diagnosed acute promyelocytic leukemia with liposomal all-trans retinoic acid, LEUK LYMPH, 42(3), 2001, pp. 309-316
Influence of the annealing ambient on the relative thermal stability of dislocation loops in silicon
Authors:
Cristiano, F
Colombeau, B
Grisolia, J
de Mauduit, B
Giles, F
Omri, M
Skarlatos, D
Tsoukalas, D
Claverie, A
Citation: F. Cristiano et al., Influence of the annealing ambient on the relative thermal stability of dislocation loops in silicon, NUCL INST B, 178, 2001, pp. 84-88
Phase I study of irofulven (MGI 114), an acylfulvene illudin analog, in patients with acute leukemia
Authors:
Giles, F
Cortes, J
Garcia-Manero, G
Kornblau, S
Estey, E
Kwari, M
Murgo, A
Kantarjian, H
Citation: F. Giles et al., Phase I study of irofulven (MGI 114), an acylfulvene illudin analog, in patients with acute leukemia, INV NEW DR, 19(1), 2001, pp. 13-20
Authors:
Cortes, J
O'Brien, S
Loscertales, J
Kantarjian, H
Giles, F
Thomas, D
Koller, C
Keating, M
Citation: J. Cortes et al., Cyclosporin A for the treatment of cytopenia associated with chronic lymphocytic leukemia, CANCER, 92(8), 2001, pp. 2016-2022
Authors:
Cortes, J
Estey, E
O'Brien, S
Giles, F
Shen, Y
Koller, C
Beran, M
Thomas, D
Keating, M
Kantarjian, H
Citation: J. Cortes et al., High-dose liposomal daunorubicin and high-dose cytarabine combination in patients with refractory or relapsed acute myelogenous leukemia, CANCER, 92(1), 2001, pp. 7-14
Authors:
Cortes, J
Estey, E
Beran, M
O'Brien, S
Giles, F
Koller, C
Keating, M
Kantarjian, H
Citation: J. Cortes et al., Cyclophosphamide, ara-C and topotecan (CAT) for patients with refractory or relapsed acute leukemia, LEUK LYMPH, 36(5-6), 2000, pp. 479-484
Authors:
Faderl, S
Kantarjian, HM
Thomas, DA
Cortes, J
Giles, F
Pierce, S
Albitar, M
Estrov, Z
Citation: S. Faderl et al., Outcome of Philadelphia chromosome-positive adult acute lymphoblastic leukemia, LEUK LYMPH, 36(3-4), 2000, pp. 263-273
Authors:
Giles, F
Brett, L
Citation: F. Giles et L. Brett, Walking among ghosts - An interview with Lily Brett, MEANJIN, 59(1), 2000, pp. 54-69
Authors:
Kantarjian, HM
Talpaz, M
O'Brien, S
Manshouri, T
Cortes, J
Giles, F
Rios, MB
Croce, CM
Albitar, M
Citation: Hm. Kantarjian et al., Significance of FHIT expression in chronic myelogenous leukemia, CLIN CANC R, 5(12), 1999, pp. 4059-4064
Authors:
Vey, N
Kantarjian, H
Tran, H
Beran, M
O'Brien, S
Bivins, C
Giles, F
Cortes, J
Cheson, B
Arbuck, S
Estey, E
Citation: N. Vey et al., Phase I and pharmacologic study of 9-aminocamptothecin colloidal dispersion formulation in patients with refractory or relapsed acute leukemia, ANN ONCOL, 10(5), 1999, pp. 577-583
Authors:
Cortes, J
O'Brien, S
Estey, E
Giles, F
Keating, M
Kantarjian, H
Citation: J. Cortes et al., Phase I study of liposomal daunorubicin in patients with acute leukemia, INV NEW DR, 17(1), 1999, pp. 81-87
Authors:
Cortes, JE
Kantarjian, HM
O'Brien, S
Giles, F
Keating, MJ
Freireich, EJ
Estey, EH
Citation: Je. Cortes et al., A pilot study of interleukin-2 for adult patients with acute myelogenous leukemia in first complete remission, CANCER, 85(7), 1999, pp. 1506-1513
Authors:
Aguayo, A
Estey, E
Kantarjian, H
Mansouri, T
Gidel, C
Keating, M
Giles, F
Estrov, Z
Barlogie, B
Albitar, M
Citation: A. Aguayo et al., Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia, BLOOD, 94(11), 1999, pp. 3717-3721
Authors:
Vey, N
Keating, M
Giles, F
Cortes, J
Beran, M
Estey, E
Citation: N. Vey et al., Effect of complete remission on survival in patients with acute myelogenous leukemia receiving first salvage therapy, BLOOD, 93(9), 1999, pp. 3149-3150
Risultati:
1-15
|